^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer

Published date:
12/09/2021
Excerpt:
...we used EGFR-overexpressing TNBC cell lines MDA-MB-468 and MDA-MB-231 to evaluate the effects of LR004-VC-MMAE on cell proliferation. The CCK-8 assay results showed that LR004-VC-MMAE inhibited the growth of MDA-MB-468 and MDA-MB-231 (Fig. 2a) cells in a dose- and time-dependent manner.
DOI:
https://doi.org/10.1186/s40779-021-00358-9